Daniel Edmonston

Jun 26, 2024 | jamanetwork.com | Daniel Edmonston |Elizabeth A. Lydon |Hillary Mulder |Karen Chiswell

Key PointsQuestion  What patient-level risk factors are associated with inadequate screening and treatment for chronic kidney disease (CKD) among people with type 2 diabetes (T2D)? Findings  In this cohort study of 316 234 participants with T2D, fewer than 25% received guideline-recommended CKD screening, and patient-level factors such as Hispanic ethnicity and comorbid cardiovascular disease were associated with concordance with screening recommendations.

Jun 1, 2024 | jacc.org | Daniel Edmonston |Hillary Mulder |Elizabeth A. Lydon |Karen Chiswell

References1. "National Diabetes Statistics Report". 2020. Accessed July 3, 2024. https://doi.org/https://www.cdc.gov/diabetes/php/data-research/data-statistics/index.html. 2. "Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES. 2007-2012". BMJ Open Diabetes Res Care . 2016;4:e000154. 3. "Kidney disease and increased mortality risk in type 2 diabetes". J Am Soc Nephrol . 2013;24:302-308. 4.

Apr 6, 2023 | kidneynews.org | Daniel Edmonston

The heart and the kidney share immense metabolic demands, overlapping stressors, and devastating diseases. Cardiovascular disease remains the predominant cause of death for people with kidney diseases. In turn, the development of chronic kidney disease portends poor outcomes and may limit guideline-directed medical therapies for people with cardiovascular disease.